RMD logo

ResMed (RMD) Accounts Payable

Annual Accounts Payable

$237.73 M
+$86.97 M+57.69%

June 30, 2024


Summary


Performance

RMD Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRMDbalance sheetmetrics:

Quarterly Accounts Payable

$220.31 M
-$28.96 M-11.62%

December 31, 2024


Summary


Performance

RMD Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRMDbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

RMD Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+57.7%+24.2%
3 y3 years+72.3%+34.9%
5 y5 years+105.4%+92.7%

RMD Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+72.3%-11.6%+47.1%
5 y5-yearat high+105.4%-11.6%+92.7%
alltimeall timeat high>+9999.0%-11.6%>+9999.0%

ResMed Accounts Payable History

DateAnnualQuarterly
Dec 2024
-
$220.31 M(-11.6%)
Sep 2024
-
$249.28 M(+4.9%)
Jun 2024
$237.73 M(+57.7%)
$237.73 M(+34.0%)
Mar 2024
-
$177.44 M(-12.3%)
Dec 2023
-
$202.40 M(+14.3%)
Sep 2023
-
$177.05 M(+17.4%)
Jun 2023
$150.76 M(-5.3%)
$150.76 M(-6.9%)
Mar 2023
-
$161.90 M(-17.4%)
Dec 2022
-
$196.00 M(+8.0%)
Sep 2022
-
$181.49 M(+14.0%)
Jun 2022
$159.25 M(+15.4%)
$159.25 M(+6.3%)
Mar 2022
-
$149.80 M(-8.3%)
Dec 2021
-
$163.37 M(-5.9%)
Sep 2021
-
$173.70 M(+25.9%)
Jun 2021
$138.01 M(+1.6%)
$138.01 M(+17.7%)
Mar 2021
-
$117.22 M(-4.0%)
Dec 2020
-
$122.17 M(+3.9%)
Sep 2020
-
$117.59 M(-13.4%)
Jun 2020
$135.79 M(+17.3%)
$135.79 M(+16.9%)
Mar 2020
-
$116.15 M(+1.6%)
Dec 2019
-
$114.32 M(+4.2%)
Sep 2019
-
$109.74 M(-5.2%)
Jun 2019
$115.72 M(+24.8%)
$115.72 M(-7.0%)
Mar 2019
-
$124.47 M(+12.8%)
Dec 2018
-
$110.33 M(+11.8%)
Sep 2018
-
$98.71 M(+6.5%)
Jun 2018
$92.72 M(-0.0%)
$92.72 M(+5.2%)
Mar 2018
-
$88.16 M(+12.5%)
Dec 2017
-
$78.35 M(-7.9%)
Sep 2017
-
$85.08 M(-8.3%)
Jun 2017
$92.76 M(+0.2%)
$92.76 M(+12.0%)
Mar 2017
-
$82.85 M(-12.0%)
Dec 2016
-
$94.10 M(+16.9%)
Sep 2016
-
$80.49 M(-13.1%)
Jun 2016
$92.57 M(+14.1%)
$92.57 M(+19.2%)
Mar 2016
-
$77.64 M(+14.9%)
Dec 2015
-
$67.58 M(-12.8%)
Sep 2015
-
$77.48 M(-4.5%)
Jun 2015
$81.11 M(-5.0%)
$81.11 M(+14.4%)
Mar 2015
-
$70.90 M(-11.4%)
Dec 2014
-
$80.00 M(+4.9%)
Sep 2014
-
$76.25 M(-10.7%)
Jun 2014
$85.41 M(+40.7%)
$85.41 M(+53.9%)
Mar 2014
-
$55.48 M(-1.3%)
Dec 2013
-
$56.23 M(-1.6%)
Sep 2013
-
$57.13 M(-5.9%)
Jun 2013
$60.69 M(+10.3%)
$60.69 M(+22.9%)
Mar 2013
-
$49.38 M(-5.2%)
Dec 2012
-
$52.12 M(-1.5%)
Sep 2012
-
$52.91 M(-3.8%)
Jun 2012
$55.01 M(-0.3%)
$55.01 M(+0.5%)
Mar 2012
-
$54.73 M(+19.6%)
Dec 2011
-
$45.76 M(-2.0%)
Sep 2011
-
$46.69 M(-15.4%)
Jun 2011
$55.19 M(-4.1%)
$55.19 M(+5.4%)
Mar 2011
-
$52.37 M(+18.1%)
Dec 2010
-
$44.33 M(+2.9%)
Sep 2010
-
$43.07 M(-25.1%)
Jun 2010
$57.53 M
$57.53 M(+11.0%)
DateAnnualQuarterly
Mar 2010
-
$51.86 M(+11.2%)
Dec 2009
-
$46.62 M(-1.4%)
Sep 2009
-
$47.29 M(-2.1%)
Jun 2009
$48.29 M(-14.2%)
$48.29 M(-5.7%)
Mar 2009
-
$51.23 M(-5.9%)
Dec 2008
-
$54.46 M(+12.3%)
Sep 2008
-
$48.48 M(-13.9%)
Jun 2008
$56.31 M(+6.2%)
$56.31 M(+59.5%)
Mar 2008
-
$35.30 M(-19.5%)
Dec 2007
-
$43.87 M(-8.9%)
Sep 2007
-
$48.15 M(-9.2%)
Jun 2007
$53.04 M(+17.7%)
$53.04 M(+20.2%)
Mar 2007
-
$44.11 M(-3.0%)
Dec 2006
-
$45.48 M(+29.3%)
Sep 2006
-
$35.18 M(-21.9%)
Jun 2006
$45.05 M(+30.9%)
$45.05 M(+27.6%)
Mar 2006
-
$35.29 M(-5.9%)
Dec 2005
-
$37.50 M(+16.5%)
Sep 2005
-
$32.19 M(-6.5%)
Jun 2005
$34.42 M(+85.3%)
$34.42 M(+48.0%)
Mar 2005
-
$23.26 M(+30.5%)
Dec 2004
-
$17.82 M(-0.7%)
Sep 2004
-
$17.95 M(-3.4%)
Jun 2004
$18.57 M(-4.1%)
$18.57 M(-0.7%)
Mar 2004
-
$18.70 M(+29.2%)
Dec 2003
-
$14.48 M(-16.8%)
Sep 2003
-
$17.41 M(-10.1%)
Jun 2003
$19.37 M(+66.9%)
$19.37 M(+20.8%)
Mar 2003
-
$16.03 M(+28.7%)
Dec 2002
-
$12.45 M(+3.6%)
Sep 2002
-
$12.02 M(+3.6%)
Jun 2002
$11.61 M(+45.6%)
$11.61 M(-6.2%)
Mar 2002
-
$12.37 M(+82.8%)
Dec 2001
-
$6.77 M(+6.2%)
Sep 2001
-
$6.37 M(-20.0%)
Jun 2001
$7.97 M(+34.4%)
$7.97 M(-16.4%)
Mar 2001
-
$9.54 M(+10.1%)
Dec 2000
-
$8.66 M(+36.3%)
Sep 2000
-
$6.36 M(+7.2%)
Jun 2000
$5.93 M(+23.5%)
$5.93 M(-27.7%)
Mar 2000
-
$8.20 M(+20.6%)
Dec 1999
-
$6.80 M(+17.2%)
Sep 1999
-
$5.80 M(+20.8%)
Jun 1999
$4.80 M(+26.3%)
$4.80 M(-12.7%)
Mar 1999
-
$5.50 M(+27.9%)
Dec 1998
-
$4.30 M(+30.3%)
Sep 1998
-
$3.30 M(-13.2%)
Jun 1998
$3.80 M(+46.2%)
$3.80 M(+81.0%)
Mar 1998
-
$2.10 M(-27.6%)
Dec 1997
-
$2.90 M(+70.6%)
Sep 1997
-
$1.70 M(-34.6%)
Jun 1997
$2.60 M(+8.3%)
$2.60 M(+52.9%)
Mar 1997
-
$1.70 M(-29.2%)
Dec 1996
-
$2.40 M(-4.0%)
Sep 1996
-
$2.50 M(+4.2%)
Jun 1996
$2.40 M(-7.7%)
$2.40 M(+4.3%)
Mar 1996
-
$2.30 M(-11.5%)
Jun 1995
$2.60 M(+73.3%)
$2.60 M(+73.3%)
Jun 1994
$1.50 M(+87.5%)
$1.50 M(+87.5%)
Jun 1993
$800.00 K
$800.00 K

FAQ

  • What is ResMed annual accounts payable?
  • What is the all time high annual accounts payable for ResMed?
  • What is ResMed annual accounts payable year-on-year change?
  • What is ResMed quarterly accounts payable?
  • What is the all time high quarterly accounts payable for ResMed?
  • What is ResMed quarterly accounts payable year-on-year change?

What is ResMed annual accounts payable?

The current annual accounts payable of RMD is $237.73 M

What is the all time high annual accounts payable for ResMed?

ResMed all-time high annual accounts payable is $237.73 M

What is ResMed annual accounts payable year-on-year change?

Over the past year, RMD annual accounts payable has changed by +$86.97 M (+57.69%)

What is ResMed quarterly accounts payable?

The current quarterly accounts payable of RMD is $220.31 M

What is the all time high quarterly accounts payable for ResMed?

ResMed all-time high quarterly accounts payable is $249.28 M

What is ResMed quarterly accounts payable year-on-year change?

Over the past year, RMD quarterly accounts payable has changed by +$42.87 M (+24.16%)